SAN FRANCISCO, Jan. 19, 2022 /PRNewswire/ — The global mutation detection kits in genome editing market size is expected to reach USD 455.1 million by 2028, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 17.3% from 2021 to 2028. Technological advancements in gene modification technologies, growing adoption of personalized medicine, and increasing demand for synthetic genes and GMOs have majorly driven the market.
Key Insights & Findings from the report:
- The CRISPR/Cas9 technology segment accounted for the largest revenue in 2020 and is expected to continue the trend in the forecast period. This can be attributed to the various advantages offered by this technique, along with expanding applications of the CRISPR/Cas9 technique
- By end-use, academic and research institutes held the largest revenue share in 2020. This is attributed to the increasing R&D activities by these end-users in the genomics space
- The CROs end-use segment is expected to witness significant growth throughout the forecast period. There exists a considerable demand for contract service providers for gene editing. An increasing number of startups and emerging companies engaged in the gene-editing process has fueled the demand for CROs in this market
- North America has emerged as the highest revenue-generating region in 2020 owing to the presence of key players and developed healthcare infrastructure
- Asia Pacific is anticipated to register the fastest CAGR throughout the forecast period. India and South Korea are majorly contributing to the regional market growth
Read 100 page market research report, “Mutation Detection Kits In Genome Editing Market Size, Share & Trends Analysis Report By Technology (CRISPR/Cas9, TALENs/MegaTALs, ZFN, Meganucleases), By End-use, By Region, And Segment Forecasts, 2021 – 2028“, by Grand View Research
The advent of CRISPR/Cas9 nuclease, TALEN, and ZFN allows easy and precise genome modification with no limitation by organisms. In recent times, this space has witnessed a slew of news emerging surrounding the advancement and application of gene editing tools for genetic disease treatment. For instance, in February 2021, researchers from the University of Illinois Chicago developed a new gene-editing tool that the programming of sequential cuts or edits over time.
COVID-19 has become a catalyst for the mutation detection kits market growth. Owing to the pandemic, the leading scientific community and market competitors are now focusing on deciphering the potential of gene editing techniques to prevent COVID-19 infection. CRISPR technology has been studied as a viable tool to alleviate the adverse impact of the pandemic and virus mutation. CRISPR can be utilized in various ways that can contribute to improving human health.
The TALENs/MegaTALs technology segment is expected to witness gradual growth from 2021 to 2028. The development of TALENs has led to major advancements in new therapy development. This technique is found to have more advanced potential gene therapy applications. The scientific community as well as operating players in the gene therapy market are showing a continued interest in the implementation of meganucleases in therapy development. Key players in the market are undertaking various strategic initiatives such as mergers & acquisitions and new product development to maintain their market presence.
Market Segmentation:
Grand View Research has segmented the global mutation detection kit in genome editing market on the basis of technology by application, end-use, and region:
- Mutation Detection Kit In Genome Editing Technology by Application Outlook (Revenue, USD Thousand, 2017 – 2028)
- CRISPR/Cas9
- Genetically Modified Organisms (GMO) Analysis
- Disease Genotyping
- Typing of Transgenic Plants
- Therapy Development
- Epigenetic Editing
- ZFN
- Genetically Modified Organisms (GMO) Analysis
- Disease Genotyping
- Typing of Transgenic Plants
- Therapy Development
- Epigenetic Editing
- TALENs/MegaTALs
- Genetically Modified Organisms (GMO) Analysis
- Disease Genotyping
- Typing of Transgenic Plants
- Therapy Development
- Epigenetic Editing
- Meganucleases
- Genetically Modified Organisms (GMO) Analysis
- Disease Genotyping
- Typing Of Transgenic Plants
- Therapy Development
- Epigenetic Editing
- Others
- Mutation Detection Kit In Genome Editing End-use Outlook (Revenue, USD Thousand, 2017 – 2028)
- Biotechnology and Pharmaceutical Companies
- Academic and Government Research Institutes
- Contract Research Organizations
- Mutation Detection Kit In Genome Editing Regional Outlook (Revenue, USD Thousand, 2017 – 2028)
- North America
- U.S.
- Canada
- Europe
- Germany
- U.K.
- France
- Spain
- Italy
- Asia Pacific
- Japan
- China
- India
- South Korea
- Latin America
- Brazil
- Mexico
- Middle East & Africa
- South Africa
- Saudi Arabia
List of Key Players of Mutation Detection Kit In Genome Editing Market
- Takara Bio Inc.
- Thermo Fisher Scientific
- Lucigen
- Integrated DNA Technologies, Inc.
- GenScript
- Promega Corporation
- Synthego
- Applied Biological Materials, Inc. (abm)
- New England Biolabs
- Bio-Rad Laboratories
- Biovision Inc.
- AddGene
Check out more studies related to gene editing & engineering, published by Grand View Research:
- Genome Editing Market Report | 2021-28 – The global genome editing market size was valued at USD 3.7 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 22.9% from 2021 to 2028. Increasing implementation of CRISPR genome editing technology coupled with rising synthetic gene demand in diverse biotechnology domains has primarily driven the market growth over the past few years.
- Gene Amplification Technologies Market Report | 2021-28 – The global gene amplification technologies market size was valued at USD 26.28 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 2.0% from 2021 to 2028. The growing need for research and development in the field of molecular diagnostics, genomics, biological research, and genetic testing is a key factor fueling market growth.
- CRISPR And Cas Genes Market Report | 2021-28 – The global CRISPR and cas genes market size was valued at USD 1.5 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 21.7% from 2021 to 2028.
Browse Through Grand View Research’s coverage of the Global Biotechnology Industry.
Gain access to Grand View Compass, our BI enabled intuitive market research database of 10,000+ reports
About Grand View Research
Grand View Research, U.S.-based market research and consulting company, provides syndicated as well as customized research reports and consulting services. Registered in California and headquartered in San Francisco, the company comprises over 425 analysts and consultants, adding more than 1200 market research reports to its vast database each year. These reports offer in-depth analysis on 46 industries across 25 major countries worldwide. With the help of an interactive market intelligence platform, Grand View Research helps Fortune 500 companies and renowned academic institutes understand the global and regional business environment and gauge the opportunities that lie ahead.
Contact:
Sherry James
Corporate Sales Specialist, USA
Grand View Research, Inc.
Phone: 1-415-349-0058
Toll Free: 1-888-202-9519
Email: [email protected]
Web: https://www.grandviewresearch.com
Follow Us: LinkedIn | Twitter
Logo: https://mma.prnewswire.com/media/661327/Grand_View_Research_Logo.jpg
